Letter to the Editor: Advancing predictive psychiatry in perinatal care: The imperative of multidimensional modeling for postpartum anxiety following preeclampsia

Abstract

The integration of predictive modeling into perinatal psychiatry represents an advancement in maternal mental healthcare. Zhang et al recently published a study in the World Journal of Psychiatry, which contributed to this emerging field by developing and validating a multivariate model for predicting clinically significant postpartum anxiety symptoms among patients with preeclampsia. Their model integrates biological (blood pressure control, hematocrit, and body mass index increase), psychological (resilience), and social (family relationship) indicators. It achieved a 0.908 area under the curve, outperforming single predictors. This letter contextualizes this work within the accelerating trend toward the multidimensional biopsychosocial prediction of perinatal mental health. Using pooled data from 15 contemporary studies (n = 4327), we demonstrate that composite models consistently outperform univariate approaches, with a mean 0.14 area under the curve improvement. Emerging trends include the transition from purely psychosocial frameworks to integrated biopsychosocial models, the exploration of novel biological markers (e.g., inflammatory cytokines and epigenetic signatures), and the critical challenge of translating statistical models into feasible and equitable clinical tools. Although Zhang et al’s model offers notable clinical immediacy, its single-center design and reliance on readily available but potentially proximal variables highlight the need for external validation and mechanistic depth. Future progress will depend on longitudinal cohorts, multi-omics integration, and implementation frameworks that address barriers in diverse healthcare settings.

Key Words: Preeclampsia; Postpartum anxiety; Predictive modeling; Biopsychosocial model; Perinatal psychiatry; Risk factors; Precision medicine; Machine learning

Core Tip: Predictive modeling is transforming perinatal psychiatry. By integrating biological, psychological, and social indicators, multivariate models, such as that proposed by Zhang et al, for predicting postpartum anxiety symptoms among patients with preeclampsia demonstrate higher predictive accuracy than single-predictor models. However, their clinical impact depends on external validation, deeper investigation of biological mechanisms, and implementation across diverse populations.

TO THE EDITOR

Preeclampsia (PE) is a multisystem hypertensive disorder of pregnancy affecting approximately 2%-8% of gestations worldwide and poses a well-established threat to maternal and fetal physical health. Beyond its acute obstetric dangers, PE is associated with profound and lasting psychological vulnerability. A recent meta-analysis by Caropreso et al[1] reported that women with PE exhibit a 2.5-fold increased risk of postpartum depression compared to those with normotensive pregnancies. Although fewer studies have focused specifically on postpartum anxiety disorder (PPAD), emerging cohort evidence suggests a similarly elevated risk[2,3], underscoring the need for integrated predictive approaches.

In response to this clinical challenge, Zhang et al[4] recently published a study in the World Journal of Psychiatry, which presented a focused and pragmatic approach. By developing a predictive model for postpartum anxiety symptoms among patients with PE based on five accessible variables, pregnancy blood pressure control, gestational body mass index increase, hematocrit (Hct), family relationships, and psychological resilience, the researchers provided a tool with immediate potential for risk stratification in obstetric settings. It should be noted that Zhang et al[4] defined the outcome using a validated symptom scale (Zung Self-Rating Anxiety Scale ≥ 40), which captures subthreshold to clinically significant anxiety, rather than formal psychiatric diagnosis. This reflects pragmatic constraints in obstetric settings but warrants caution in generalizing findings to diagnostic-level PPAD.

Although postpartum anxiety and depression are frequently comorbid and share overlapping risk factors, they represent distinct clinical syndromes with differing symptom profiles, trajectories, and treatment implications[3]. Zhang et al’s original study[4] specifically targeted postpartum anxiety symptoms, motivated by growing recognition that anxiety, often underdiagnosed in perinatal settings, may precede or persist independently of depressive episodes[2,3]. Our editorial accordingly focuses on postpartum anxiety to maintain fidelity to the primary study while acknowledging the broader relevance of predictive modeling for all perinatal mood and anxiety disorders (PMADs).

This work exemplifies a broader paradigm shift in perinatal psychiatry: A movement away from identifying associations and towards building predictive and actionable models. For decades, research has cataloged numerous risk factors for PMADs, spanning demographic, obstetric, psychiatric, and social support domains. However, clinical translation has been limited by the modest predictive power of individual factors and the complexity of their interactions. The contemporary trend, as exemplified by Zhang et al[4], increasingly embraces this complexity through multivariate modeling, aiming to generate quantifiable risk estimates that can guide personalized monitoring and preventive interventions. This editorial critically examines this research trend, evaluates the methodological evolution, synthesizes evidence on model performance, and outlines key challenges, including those related to validation, biological mechanism discovery, and clinical implementation, that must be addressed to realize the promise of predictive perinatal psychiatry.

Evidence synthesis approach

To support our assertion that multivariate models consistently outperform univariate approaches in predicting PMADs, we conducted a rapid evidence synthesis of peer-reviewed studies published between 2018 and 2025. We identified relevant articles through targeted searches in PubMed and Web of Science using combinations of terms such as “prediction model”, “postpartum depression/anxiety”, “AUC”, and “discrimination”. Inclusion criteria were: (1) Development or validation of a multivariate prediction model for PMADs; (2) Direct comparison of model performance between composite and single-predictor approaches; and (3) Reporting of area under the curve (AUC) for both. From an initial set of 37 candidate studies, 15 met all criteria and provided sufficient detail for quantitative comparison (total n = 4327 participants). For each study, we extracted the AUC of the best-performing univariate predictor and the AUC of the full multivariate model; the mean AUC gain (0.14) reflects the average within-study difference. Given heterogeneity in outcome definitions (e.g., symptom scales vs clinical diagnoses), timing of assessment (antenatal vs postpartum), and population characteristics, we present this as a descriptive synthesis rather than a formal meta-analysis. Visual inspection of funnel plots did not suggest substantial publication bias, though statistical tests were underpowered due to the limited number of comparable studies.

The multidimensional shift: From isolated risks to integrated models

The model proposed by Zhang et al[4] is firmly situated in the biopsychosocial framework, which is increasingly recognized as essential for understanding PMAD. Historically, research on PPAD after PE has focused heavily on psychosocial stressors or prior psychiatric history. However, in recent years, concerted efforts have been made to integrate the distinctive biological sequelae of PE into etiological and predictive models (Table 1). PE is not only a vascular event but also a state of systemic inflammation, oxidative stress, endothelial dysfunction, and potential neurovascular injury. These biological perturbations may create latent vulnerability to affective disorders during the postpartum period, a time characterized by heightened neuroendocrine flux and psychological adjustment. Zhang et al[4] incorporated this integrative approach by including Hct, a marker of hemoconcentration and inflammation frequently elevated in PE, and blood pressure control, a proxy for disease severity and potential cerebral perfusion issues. This approach aligns with a growing body of literature linking PE-associated biomarkers to postpartum mental health outcomes. For instance, dysregulated inflammatory cytokines, including interleukin-6 and tumor necrosis factor-α, observed in PE have been independently correlated with postpartum depression, suggesting shared biological pathways[5,6]. Furthermore, neuroimaging studies have identified subtle white matter alterations and changes in functional connectivity in the brains of individuals with a history of PE, which may underlie their cognitive and emotional vulnerabilities[7,8].

Table 1 Evolution of predictive indicators for postpartum anxiety in high-risk obstetric populations.

Model generation	Typical predictors	Theoretical focus	Key limitation	Exemplary study (AUC)1
First (psychosocial)	Past anxiety/depression, low social support, low income, low resilience	Psychosocial stress and vulnerability	Neglects biological context of medical comorbidities	AUC approximately 0.72[3]
Second (obstetric-biological)	Pregnancy complications (PE, GDM), biomarker levels (Hct, CRP), delivery trauma	Specific disease pathophysiology and stress	Often cross-sectional or single-center; biomarkers may be proximal	AUC = 0.908[4]
Third (integrated multi-omics)	Polygenic risk scores, epigenetic markers (DNA methylation), proteomic/metabolomic profiles, neuroimaging data	Systems biology and neurodevelopment	Costly, complex analysis, requires large cohorts; clinical feasibility low	Emerging studies (e.g., integration of PRS for depression)[14]
Trend	Increasing dimensionality, moving from readily available to mechanistic biomarkers, integrating data types

¹Area under the curve values are study-specific and reflect performance under original conditions; they are not directly comparable across studies due to differences in populations, outcome definitions, timing, and modeling methods.

PE: Preeclampsia; GDM: Gestational diabetes mellitus; Hct: Hematocrit; CRP: C-reactive protein; PRS: Polygenic risk score; AUC: Area under the curve.

The superiority of Zhang et al’s composite model[4] (AUC = 0.908) compared to its individual components (AUCs: 0.794-0.840) is not an isolated finding. A synthesis of recent studies that developed multivariate models for PMAD in various high-risk groups revealed a similar pattern. For example, a model for postpartum depression following preterm birth that incorporated cytokine levels, childhood trauma, and partner support significantly outperformed models based on a single domain. This underscores a fundamental principle that the etiology of PPAD, particularly in the context of biological stressors such as PE, is multifactorial and interactive. A history of anxiety (psychological) may lower the threshold at which poor blood pressure control (biological) triggers significant distress, and this relationship may be buffered or exacerbated by family support (social). Multivariable models are uniquely equipped to capture these interactions, moving beyond the question of “what is associated?” to the more clinically useful “what is the combined risk for this patient?”.

Critical appraisal: Strengths and limitations of the current paradigm

Zhang et al’s study[4] demonstrates several strengths that define the current best practices. The use of a standardized, validated outcome (Zung Self-Rating Anxiety Scale), the application of multivariate logistic regression with appropriate goodness-of-fit testing, and notably, the presentation of a nomogram for clinical use is commendable. The inclusion of psychological resilience, a modifiable protective factor, extends the model beyond a purely risk-focused framework, enabling the identification of targets for intervention (e.g., resilience-building programs)[9]. However, this study reflects on the common limitations of this nascent field. First, the single-center cross-sectional design restricts generalizability and precludes causal inferences. Second, “blood pressure control” conflates medication adherence, physiological response, and care quality, limiting its interpretability. Incorporating more granular pharmacokinetic or pharmacodynamic data could improve precision. Third, Hct and late-pregnancy body mass index were assessed proximally to the outcome, raising concerns about reverse causality. For example, elevated Hct may function as a causal risk factor for anxiety or as a marker of severe PE, with the overall burden and traumatic experience contributing to anxiety. In its current form, the model cannot distinguish between these two possibilities. Fourth, external validation in independent, multi-center cohorts remains pending. The reported “clinical validation” appears to rely on a temporal split-sample or subsequent sample drawn from the same institution, which offers limited assurance of transportability across diverse healthcare settings or populations. To advance toward equitable implementation, the next validation phase should include: (1) External validation in geographically and demographically distinct cohorts; (2) Subgroup analyses by race/ethnicity, socioeconomic status, and parity to assess fairness; (3) Temporal validation to evaluate model stability over time; and (4) Reporting of calibration metrics and clinical decision impact, such as changes in referral rates or intervention uptake. Such a validation package aligns with the principles of equity and feasibility emphasized in our framework.

While the high discrimination (AUC = 0.908) reported by Zhang et al[4] is encouraging, real-world clinical utility depends not only on discrimination but also on calibration, the agreement between predicted probabilities and observed outcomes across risk strata, and net benefit at clinically meaningful decision thresholds. Without calibration plots or decision curve analysis, it remains unclear whether the model’s risk estimates are well-aligned with actual event rates or whether its use would lead to more appropriate interventions compared to current practice. Furthermore, integration into routine obstetric workflows requires consideration of implementation factors such as timing of assessment, staff burden, and clear pathways for follow-up based on risk stratification. These elements are essential to ensure that statistical promise translates into tangible clinical value.

Finally, overoptimism (overfitting) is a notorious challenge in predictive modeling, particularly for multiple predictors relative to the number of outcome events. These concerns underscore the importance of adhering to established methodological standards for prediction model development and evaluation. The TRIPOD (Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis) statement provides essential guidance for transparent reporting[10], while the PROBAST (Prediction model Risk Of Bias Assessment Tool) offers a structured approach to assessing risk of bias and applicability[11]. Future studies in perinatal psychiatry would benefit from explicit alignment with these frameworks to enhance reproducibility, reduce overoptimism, and strengthen clinical credibility. Addressing this limitation requires rigorous external validation across geographically and demographically distinct populations, as demonstrated by large-scale initiatives such as the Born-in-Guangzhou cohort study, which seeks to validate mental health prediction models across diverse Chinese subpopulations[12]. Notably, Zhang et al’s work[4] builds upon earlier efforts such as Lin et al’s prediction model[13] for postpartum anxiety in women with PE[13], which also incorporated biopsychosocial variables but achieved a lower discriminative accuracy (AUC = 0.82). The improved performance in Zhang et al’s model[4] may reflect refinements in variable selection (e.g., inclusion of Hct as an inflammatory proxy) and more rigorous statistical calibration.

Future directions: Toward mechanistic, equitable, and implementable models

The future direction of predictive psychiatry in perinatal care is shaped by several interconnected imperatives that extend beyond the establishment of statistical correlations. A fundamental shift must occur from merely identifying associations to elucidating underlying biological mechanisms. This necessitates the incorporation of biomarkers that function as putative mechanistic mediators, such as those related to the gut-brain axis (via microbiome profiles), latent neuroinflammation (assessed through targeted neuroimaging or cerebrospinal fluid markers markers), and enduring epigenetic changes triggered by conditions, such as PE. For instance, the differential DNA methylation in stress-response genes, including FKBP5 and NR3C1, observed following PE offers a potential molecular link to long-term psychiatric vulnerability, moving the field toward a more causal understanding[14].

Furthermore, embracing the complexity of perinatal mental health requires advances beyond traditional analytical approaches. Although clinically friendly, tools such as logistic regression may be insufficient for modeling nonlinear interactions and high-dimensional data derived from electronic health records, wearables, and digital phenotyping. Consequently, more sophisticated machine-learning algorithms, such as random forests and gradient boosting, are being actively explored[15]. However, the ethical imperative for explainable artificial intelligence in this sensitive domain is paramount. Clinicians must be able to interpret a model’s reasoning to appropriately trust and act upon its predictions.

Finally, the ultimate test and ethical foundation of any predictive model lies in prioritizing equity and feasibility of implementation. A model validated in one specific population, such as an urban Chinese cohort, may fail catastrophically in different cultural or socioeconomic contexts, since key constructs, such as “family relationship harmony” are deeply culturally embedded[16]. Therefore, rigorous testing of fairness and calibration across diverse subgroups is essential. Equally important is addressing the “last mile” problem of implementation: Determining how to integrate a screening tool into a busy clinical workflow and establishing ethical protocols for disclosing risk without causing iatrogenic anxiety[17]. Thus, foundational studies must be followed by implementation science research that designs and tests low-burden equitable pathways to integrated care.

Conclusion

The work of Zhang et al[4] is a robust and clinically relevant contribution to the modern push toward predictive modeling in perinatal mental health. Their model successfully integrated biopsychosocial indicators to create a tool with promising discriminatory accuracy for PPAD following PE. The true value of this study, however, extends beyond its specific algorithm. More importantly, it exemplifies a necessary trend: The concerted effort to translate the established complexity of PMAD etiology into quantifiable, personalized risk estimates.

However, advancing along this path is challenging. It demands large, diverse longitudinal cohorts for discovery and validation, a deeper investigation into the biological mechanisms linking obstetric pathology with psychiatric sequelae, and a steadfast commitment to developing tools that are statistically sophisticated as well as clinically actionable, ethically sound, and equitable.

While the work of Zhang et al[4] represents a promising step toward personalized risk estimation, it is crucial to temper optimism with methodological humility. The field has not yet identified a definitive set of causal risk factors for perinatal psychiatric disorders. Consequently, current predictive models should be viewed as hypothesis-generating tools rather than clinical standards. Their ultimate value lies not in immediate implementation, but in guiding future research toward mechanistic validation, external replication, and, critically, intervention trials that test whether early identification translates into improved outcomes. Only through such iterative cycles can we responsibly advance from risk prediction toward targeted prevention.